phase readout
saveNCT07498907: Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma
NOT_YET_RECRUITINGupdated 12m ago
community read0 votes
Sponsor: Peking University First Hospital. Phase: PHASE2. Conditions: Upper Tract Urothelial Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that